These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34372782)

  • 21. [Anticoagulant treatment in elderly patients with atrial fibrillation: position paper].
    Hanon O; Jeandel C; Jouanny P; Paccalin M; Puisieux F; Krolak-Salmon P; Berrut G
    Geriatr Psychol Neuropsychiatr Vieil; 2019 Dec; 17(4):341-355. PubMed ID: 31848123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

  • 23. Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation.
    Tzeis S; Savvari P; Skiadas I; Patsilinakos S; Stamatelopoulos K; Kourouklis S; Kyrikos S; Tsatiris K; Menegas D; Hahalis G; Giannakoulas G;
    J Thromb Thrombolysis; 2021 Jan; 51(1):81-88. PubMed ID: 32519166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study.
    Barrios V; Escobar C; Prieto L; Osorio G; Polo J; Lobos JM; Vargas D; García N
    Rev Esp Cardiol (Engl Ed); 2015 Sep; 68(9):769-76. PubMed ID: 26169326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
    Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
    Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.
    Safouris A; Anagnostis P; Karlovasitou A; Karras S; Karagiannis A
    Angiology; 2014 May; 65(5):372-8. PubMed ID: 23620311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program.
    López-Sendón JL; Alonso-Rodríguez D; Barón-Esquivias G; Cosin-Sales J; Marín F; Galera-Llorca J; Jiménez N; Marler S; Huisman MV; Lip GYH;
    Med Clin (Barc); 2022 Aug; 159(4):177-182. PubMed ID: 34895750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation.
    Fernández CS; Gullón A; Formiga F
    J Comp Eff Res; 2020 May; 9(7):509-523. PubMed ID: 32329353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant treatment in elderly patients with atrial fibrillation: a position paper.
    Hanon O; Jeandel C; Jouanny P; Paccalin M; Puisieux F; Krolak-Salmon P; Berrut G
    Geriatr Psychol Neuropsychiatr Vieil; 2019 Dec; 17(4):341-354. PubMed ID: 32912842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
    Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation.
    Shah BR; Scholtus E; Rolland C; Batscheider A; Katz JN; Nilsson KR
    Curr Med Res Opin; 2019 Jan; 35(1):127-139. PubMed ID: 30380959
    [No Abstract]   [Full Text] [Related]  

  • 35. Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation.
    Jedsadayanmata A
    J Med Assoc Thai; 2013 Jan; 96(1):91-8. PubMed ID: 23720984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unresolved issues in the use of direct acting oral anticoagulants.
    Chan N; Hirsh J
    Expert Rev Cardiovasc Ther; 2023; 21(12):913-921. PubMed ID: 37837206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.
    Stolk LM; de Vries F; Ebbelaar C; de Boer A; Schalekamp T; Souverein P; Ten Cate-Hoek A; Burden AM
    Br J Clin Pharmacol; 2017 Aug; 83(8):1835-1843. PubMed ID: 28326589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience.
    Talerico R; Brando E; Luzi L; Vedovati MC; Giustozzi M; Verso M; Di Gennaro L; Basso M; Ferretti A; Porfidia A; De Candia E; Pola R; Agnelli G; Becattini C
    Intern Emerg Med; 2024 Sep; 19(6):1645-1652. PubMed ID: 38943034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
    Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
    Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
    Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.